KEY SUMMARY: WebMD has been sold to an investment group and you can bet that there are going to be some big changes coming to the number one health portal that might not include a strategy to attract online pharma dollars.
WebMD
KEY TAKEAWAY: The correlation between traffic for a healthcare site and ROI is proving more elusive as consumers spend more time debating various treatment options yet drugmakers continue down a path of “build it and they will come”. Think of the journey to treatment rather than just a digital component.